Proactive’s Post

View organization page for Proactive, graphic

21,556 followers

NanoViricides (NYSE-A:NNVC) CEO Anil Diwan joined Proactive to discuss the promise of its lead drug NV-387 as a broad-spectrum antiviral. Diwan explained that NV-387, a host mimetic drug, works differently from traditional antiviral treatments by mimicking a natural cellular feature, making it difficult for viruses to escape. He highlighted successful preclinical and early clinical results, noting the drug's effectiveness against viruses like RSV, influenza, and more recently, monkeypox (MPOX). Proactive: Really interesting news out from the World Health Organization about monkeypox. We'll talk about that in just a second. But this relates to your drug... http://ow.ly/qH1N105IHKh

  • No alternative text description for this image

To view or add a comment, sign in

Explore topics